ArticleEuropean journal of pediatrics2026
Peculiarity of preterm neonates at 33-35 weeks gestational age with mild-to-severe hypoxic-ischaemic encephalopathy: a single-centre experience.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To describe the peculiarity of preterm neonates at 33-35 weeks gestational age (GA) with mild-to-severe hypoxic-ischaemic encephalopathy (HIE). This single-centre retrospective study compared the background characteristics, treatments, and outcomes of 30 preterm HIE neonates at 33-35 weeks GA with those of 399 HIE neonates at ≥ 36 weeks GA between 2011 and 2023. Between the 33-35 weeks and 36, 37-40, or ≥ 41 weeks GA groups, HIE severity and use of therapeutic hypothermia (TH) were not significantly different. Between the 33-35 weeks and 37-40 weeks GA groups, no TH, except for mild HIE, was significantly different (35% vs. 3%) and the incidence of moderate-to-severe magnetic resonance imaging (MRI) injury was significantly different (43% vs. 19%); the white matter injury was predominant. Moderate-to-severe MRI injury was associated with lower GA (odds ratio 0.81 [95% confidential intervals, 0.67-0.98]), but total adverse outcomes, including death before discharge and long-term outcomes over 2 years, were not significantly different among the groups and were not associated with GA.
conclusionIn this study, preterm neonates at 33-35 weeks GA, some of who were unable to receive TH because of reasons, except for mild HIE, were at risk of moderate-to-severe MRI injury, but their total adverse outcome was comparable to that of preterm neonates at ≥ 36 weeks GA. Further research including mild-to-severe HIE regardless of TH are needed. WHAT IS KNOWN: ・TH for preterm neonates at 33-35 weeks GA with moderate or severe HIE does not affect neurodevelopmental outcomes at 18 months. ・TH for preterm neonates with moderate or severe HIE may not increase neurodevelopmental impairment compared with term or near-term neonates. WHAT IS NEW: ・Preterm neonates at 33-35 weeks GA with mild-to-severe HIE were at risk of moderate-to-severe MRI injury, but death and long-term outcomes over 2 years were comparable to those of preterm neonates at ≥ 36 weeks GA. ・Some preterm neonates with moderate or severe HIE did not use TH because of poor conditions.
Indexed as
Identifiers
41652106What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.